Source comparison
TB-500 Muscle Tear Mechanism: Research-Grade Comparison
TB-500 (Thymosin Beta-4) Actin sequestration, satellite cell migration, MMP upregulation Acute to subacute (0–14 days post-injury) 2–5 mg, 2–3×/week for 4 weeks 30–40% reduction vs controls Gold standard for mechanical tissue tears where collagen realignment i
This comparison does not assign a generated winner or score.
- TB-500 (Thymosin Beta-4)
- Actin sequestration, satellite cell migration, MMP upregulation
- Acute to subacute (0–14 days post-injury)
- 2–5 mg, 2–3×/week for 4 weeks
- 30–40% reduction vs controls
- Gold standard for mechanical tissue tears where collagen realignment is critical. Strongest evidence base for muscle-specific repair
- BPC-157
- VEGF upregulation, nitric oxide modulation, growth hormone receptor interaction
- Acute to chronic (effective across all phases)
- 250–500 mcg daily for 4–6 weeks
- 20–30% reduction vs controls
- Broader tissue applicability (tendons, ligaments, GI) but less potent for pure muscle tears. Better suited for multi-tissue injuries
- GHK-Cu (Copper Peptide)
- Direct collagen synthesis stimulation, antioxidant enzyme activation
- Subacute to remodeling (7–28 days post-injury)
- 1–3 mg, 3×/week for 4 weeks
- 15–25% reduction vs controls
- Enhances cosmetic and structural outcomes but minimal effect on satellite cell dynamics. Secondary choice for muscle tears
- IGF-1 LR3
- Insulin-like growth factor receptor activation, protein synthesis upregulation
- Subacute to chronic (used after inflammatory phase)
- 40–80 mcg daily for 4 weeks
- 10–20% reduction vs controls
- Promotes hypertrophy and strength recovery post-healing but doesn't address acute repair mechanics. Tertiary to TB-500 in injury protocols